FDA fees irk device makers (Pioneer Press)
Lobbying groups representing Fridley-based Medtronic Inc., Boston Scientific Corp. and other medical-device makers are fighting with U.S. regulators over fees they must pay to seek approval to market their products.

Serono's Oral Cladribine for the Treatment of Multiple Sclerosis Awarded Fast Track Status By FDA (RedNova)
GENEVA, Switzerland, September 21 /PRNewswire-FirstCall/ -- Serono (virt-x: SEO and NYSE: SRA) announced today that oral cladribine has been designated a Fast Track product by the US Food and Drug Administration (FDA). This designation covers patients with relapsing forms of multiple sclerosis.